Literature DB >> 19488080

Parkinson disease: Pain in Parkinson disease: the hidden epidemic.

Blair Ford.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19488080     DOI： 10.1038/nrneurol.2009.50

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  5 in total

1.  Pain and motor complications in Parkinson's disease.

Authors:  M Tinazzi; C Del Vesco; E Fincati; S Ottaviani; N Smania; G Moretto; A Fiaschi; D Martino; G Defazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

2.  Pain in Parkinson's disease: Prevalence and characteristics.

Authors:  A G Beiske; J H Loge; A Rønningen; E Svensson
Journal:  Pain       Date:  2008-12-18       Impact factor: 6.961

3.  Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey.

Authors:  Laurence Nègre-Pagès; Wafa Regragui; Didier Bouhassira; Héléne Grandjean; Olivier Rascol
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

4.  Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study.

Authors:  Giovanni Defazio; Alfredo Berardelli; Giovanni Fabbrini; Davide Martino; Emiliana Fincati; Antonio Fiaschi; Giuseppe Moretto; Giovanni Abbruzzese; Roberta Marchese; Ubaldo Bonuccelli; Paolo Del Dotto; Paolo Barone; Elisa De Vivo; Alberto Albanese; Angelo Antonini; Margherita Canesi; Leonardo Lopiano; Maurizio Zibetti; Giuseppe Nappi; Emilia Martignoni; Paolo Lamberti; Michele Tinazzi
Journal:  Arch Neurol       Date:  2008-09

5.  Painful Parkinson's disease.

Authors:  N P Quinn; W C Koller; A E Lang; C D Marsden
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321
  5 in total
  9 in total

Review 1.  Integrated Approach for Pain Management in Parkinson Disease.

Authors:  Christian Geroin; Marialuisa Gandolfi; Veronica Bruno; Nicola Smania; Michele Tinazzi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

2.  Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.

Authors:  Matthew F Lazenka; Kelen C Freitas; Sydney Henck; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2017-04-14       Impact factor: 4.030

Review 3.  A key role of the basal ganglia in pain and analgesia--insights gained through human functional imaging.

Authors:  David Borsook; Jaymin Upadhyay; Eric H Chudler; Lino Becerra
Journal:  Mol Pain       Date:  2010-05-13       Impact factor: 3.395

Review 4.  Management of motor and non-motor symptoms in Parkinson's disease.

Authors:  Fabienne Sprenger; Werner Poewe
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

5.  Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.

Authors:  Jane A Driver; Giancarlo Logroscino; Linda Lu; J Michael Gaziano; Tobias Kurth
Journal:  BMJ       Date:  2011-01-20

6.  Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients.

Authors:  Wiebke Grashorn; Odette Schunke; Carsten Buhmann; Katarina Forkmann; Sabrina Diedrich; Katharina Wesemann; Ulrike Bingel
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

7.  Conditioned pain modulation in drug-naïve patients with de novo Parkinson's disease.

Authors:  Wiebke Grashorn; Odette Fründt; Carsten Buhmann; Nathalie Wrobel; Katharina Schmidt; Ulrike Bingel
Journal:  Neurol Res Pract       Date:  2019-08-26

8.  Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson's disease: implication of acrolein and TRPA1.

Authors:  Liangqin Shi; Yazhou Lin; Yucheng Jiao; Seth A Herr; Jonathan Tang; Edmond Rogers; Zhengli Chen; Riyi Shi
Journal:  Transl Neurodegener       Date:  2021-04-28       Impact factor: 8.014

9.  The Effect of Rotigotine Extended-Release Microspheres Alone or With Celecoxib on the Inflammatory Pain.

Authors:  Keke Li; Yijia Zhang; Enming Tian; Zikai Liu; Tian Wang; Fenghua Fu
Journal:  Front Pharmacol       Date:  2020-10-30       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.